Education
About Us
Working with TipRanks
Follow Us
Aligos Therapeutics (ALGS)
NASDAQ:ALGS
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 3.94M | $ 15.53M | $ 13.91M | $ 4.36M | $ 0.00 |
| Gross Profit | $ 3.94M | $ 12.46M | $ 10.23M | $ -99.79M | $ -3.33M |
| Operating Income | $ -89.15M | $ -88.13M | $ -97.58M | $ -128.32M | $ -97.83M |
| EBITDA | $ -89.15M | $ -85.06M | $ -93.91M | $ -124.54M | $ -105.06M |
| Net Income | $ -131.21M | $ -87.68M | $ -96.05M | $ -128.33M | $ -108.54M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 56.94M | $ 135.70M | $ 125.83M | $ 190.73M | $ 243.51M |
| Total Assets | $ 70.09M | $ 151.53M | $ 146.69M | $ 235.37M | $ 265.30M |
| Total Debt | $ 8.38M | $ 11.14M | $ 12.57M | $ 14.46M | $ 13.01M |
| Net Debt | $ -28.62M | $ -124.57M | $ -68.77M | $ -172.36M | $ -207.38M |
| Total Liabilities | $ 99.07M | $ 59.45M | $ 42.79M | $ 50.64M | $ 45.26M |
| Stockholders' Equity | $ -28.97M | $ 92.08M | $ 103.90M | $ 184.73M | $ 220.04M |
| Cash Flow | |||||
| Free Cash Flow | $ -80.87M | $ -79.02M | $ -80.33M | $ -116.55M | $ -76.33M |
| Operating Cash Flow | $ -80.74M | $ -79.00M | $ -79.39M | $ -115.66M | $ -74.26M |
| Investing Cash Flow | $ -18.28M | $ 44.98M | $ -26.29M | $ 3.02M | $ 32.76M |
| Financing Cash Flow | $ 355.00K | $ 88.33M | $ 164.00K | $ 78.68M | $ 192.35M |